Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 28Neoplasms by Site 2Neoplasms 2Neoplasm Metastasis 2Breast Diseases 2Advanced Breast Cancer 2Sleep Wake Disorders 1Skin Diseases 1Sexual Dysfunctions, Psychological 1Inflammatory Breast Neoplasms 1Hormone-receptor-positive Breast Cancer 1Highly Endocrine Responsive Operable Breast Cancer 1Fatigue 1Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer 1Carcinoma, Ductal, Breast 1Breast Neoplasms, Male 1Anatomic Stage III Breast Cancer AJCC v8 1

Interventions

Fulvestrant 19Letrozole 10Anastrozole 8Capecitabine 5palbociclib 4olaparib 4Paclitaxel 4Injections 4Goserelin 4Docetaxel 4trastuzumab deruxtecan 3pyrotinib 3exemestane 3Vinorelbine 3Aromatase Inhibitors 3toripalimab 2sacituzumab govitecan 2ribociclib 2eribulin 2elacestrant 2dalpiciclib 2abemaciclib 2Trastuzumab 2Gonadotropin-Releasing Hormone 2FCN-437c 2Everolimus 2Dasatinib 2Alpelisib 2Albumin-Bound Paclitaxel 2AZD9833 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Advanced Breast Cancer × Gonadotropin-Releasing Hormone × Breast × Clear all
NCT06382948 2026-04-03

ADELA

MedSIR

Phase 3 Recruiting
240 enrolled
Breast

Advanced Breast Cancer

NCT01311037 2011-12-13

The Combination of GnRh Analogue and Aromatase Inhibitor in Receptor Positive Premenopausal Women With Advanced Breast Cancer

King Faisal Specialist Hospital & Research Center

Unknown
2 enrolled
Breast

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡